Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/11/16  and contains information from public web pages and contributions from the ZoomInfo community.

Ms. Melinda Y. Costin

Wrong Melinda Y. Costin?

Vice President and Chief Informat...

Phone: (817) ***-****  
Email: m***@***.org
John Peter Smith Hospital
1500 S. Main
Fort Worth , Texas 76104
United States

Company Description: JPS serves the needs of families in Tarrant County, working to improve health status and access to health care. The JPS Network includes 459 licensed inpatient beds...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Nursing Informatics
    Summer Institute
68 Total References
Web References
Costin honored as one of most ...
dev.jpshealthcareers.com [cached]
Costin honored as one of most powerful women in healthcare: CIO-IT execs
Melinda Costin, vice president and chief information officer at JPS Health Network, has been named one of the most powerful women in healthcare information technology by Health Data Management, a leading source of healthcare IT news.
"With a career that spans the development of many of the products now common in hospitals, Costin has shared her accumulated knowledge with her colleagues and influenced the growth of health IT," the magazine's editors said.
Melinda Costin, vice ...
dev.jpshealthcareers.com [cached]
Melinda Costin, vice president and chief information officer at JPS Health Network, has been named one of the most powerful women in healthcare information technology by Health Data Management, a leading source of healthcare IT news.
"With a career that spans the development of many of the products now common in hospitals, Costin has shared her accumulated knowledge with her colleagues and influenced the growth of health IT," the magazine's editors said. "In her various position, she has led the development and implementation of products that support electronic health records, including in the area of clinical decision support."
Costin's career in healthcare IT spans 32 years. She is a member of the Healthcare Information and Management Systems Society and the College of Healthcare Information Management Executives, "and is a frequent presenter on IT topics."
Executive and Administrative Staff
www.jpshealthnet.org [cached]
Melinda Costin
...
Melinda Costin Chief Information Officer
New strides being made in chemoprevention
www.eurekalert.org [cached]
"Even at low-doses, CDDO-Im induces cell protecting genes, inhibits DNA damage by aflatoxin and dramatically blocks development of liver tumors," according to Melinda Yates of Johns Hopkins University and lead author of the study.
As described in their study, laboratory rats were given CDDO-Im three days per week for three weeks, with doses ranging from from 1 to 100 ìmol/kg body weight.Beginning one week after the start of CDDO-Im, they were given daily doses over a two-week period of aflatoxin B1, a known cancer-causing agent produced by molds in stored agricultural crops.
Aside from the significant reduction in liver tumor formation, the scientists also confirmed that CDDO-Im activated Nrf2, a gene that acts as a master regulator of the majority of antioxidant pathways and detoxifying enzymes for environmental pollutants.
"The unparalleled potency of CDDO-Im in rats highlights the chemopreventive promise of targeting Nrf2 pathways with triterpenoids, and provides a new direction for drug development," said Dr. Yates.
...
Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Synthetic Triterpenoid, CDDO-Imidazole Abstract # 2497, Melinda Yates and Thomas Kensler, John Hopkins University, Baltimore, Md.
New strides being made in chemoprevention
www.brightsurf.com [cached]
"Even at low-doses, CDDO-Im induces cell protecting genes, inhibits DNA damage by aflatoxin and dramatically blocks development of liver tumors," according to Melinda Yates of Johns Hopkins University and lead author of the study.
As described in their study, laboratory rats were given CDDO-Im three days per week for three weeks, with doses ranging from from 1 to 100 ìmol/kg body weight.Beginning one week after the start of CDDO-Im, they were given daily doses over a two-week period of aflatoxin B1, a known cancer-causing agent produced by molds in stored agricultural crops.
Aside from the significant reduction in liver tumor formation, the scientists also confirmed that CDDO-Im activated Nrf2, a gene that acts as a master regulator of the majority of antioxidant pathways and detoxifying enzymes for environmental pollutants.
"The unparalleled potency of CDDO-Im in rats highlights the chemopreventive promise of targeting Nrf2 pathways with triterpenoids, and provides a new direction for drug development," said Dr. Yates.
Other People with the name "Costin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.